BioLife Solutions, Inc.BLFSNASDAQ

Revenue (LTM)

$96M

+17.0% YoY

Net Income (LTM)

$-12M

+39.9% YoY

Free Cash Flow

$11M

Revenue CAGR (5Y)

+14.9%

Marginsimproving

FCF$0.0B

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	119	76↓36.0%	76↓0.5%	82↑8.4%	96↑17.0%
Gross Profit	29	47↑62.6%	47↓0.3%	54↑14.8%	62↑15.7%
Operating Income	-35	-6↑83.2%	-23↓295.7%	-7↑69.6%	-12↓70.2%
Net Income	-9	-140↓1469.4%	-66↑52.5%	-20↑69.6%	-12↑39.9%
EBITDA	-17	-124↓645.7%	-45↑63.6%	2↑103.4%	-9↓711.9%
EPS Diluted	-0.23	-3.29↓1330.4%	-1.52↑53.8%	-0.44↑71.1%	-0.25↑43.2%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	70	19↓72.2%	28↑43.5%	95↑241.9%	33↓65.4%
Total Current Assets	126	138↑10.0%	121↓12.9%	149↑23.3%	120↓19.2%
Total Assets	553	450↓18.5%	413↓8.3%	399↓3.2%	406↑1.6%
Total Current Liabilities	43	45↑4.4%	42↓5.4%	33↓22.4%	23↓29.8%
Total Liabilities	76	86↑12.9%	75↓12.8%	51↓32.6%	34↓32.8%
Total Equity	481	364↓24.2%	338↓7.3%	349↑3.3%	372↑6.6%
Total Debt	27	44↑62.6%	34↓22.6%	30↓10.8%	18↓40.7%
Net Debt	-43	24↑156.5%	6↓75.6%	-65↓1199.5%	-15↑76.8%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-5	-8↓75.5%	-12↓47.2%	8↑167.5%	20↑138.6%
Capital Expenditure	-8	-10↓23.9%	-6↑38.6%	-3↑49.4%	-9↓193.7%
Free Cash Flow	-13	-19↓42.8%	-19↓0.0%	5↑127.6%	11↑104.4%
Stock-Based Comp	14	25↑81.5%	32↑25.0%	31↓2.4%	0
Net Change in Cash	-21	-50↓144.8%	16↑131.7%	60↑275.5%	-62↓204.0%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance